CVRx (CVRX)

• Market cap: $205M
• 1 day: -4.49%
• 5 days: -0.38%
• 1 month: 4.79%
• 3 months: 32.72%
• 6 months: -32.33%
• Year to date: -42.05%
• 1 year: 3.42%
• 5 years: -71.89%
• 10 years: -71.89%
• Sector: Healthcare
• Industry: Medical Devices

About: CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Employees: 206

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

84% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 19

46% more call options, than puts

Call options by funds: $331K | Put options by funds: $227K

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

3% less funds holding

Funds holding: 95 [Q1] → 92 (-3) [Q2]

5.46% less ownership

Funds ownership: 61.34% [Q1] → 55.87% (-5.46%) [Q2]

13% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 23

56% less capital invested

Capital invested by funds: $195M [Q1] → $85.4M (-$110M) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $11
• Avg. target: $11
• High target: $11

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Cantor Fitzgerald Ross Osborn

$11

Overweight Reiterated

5 Aug 2025